^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Thyroid GuidePx®

    Company:
    Protean BioDiagnostics, Qualisure Diagnostics
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    Thyroid GuidePx® is a prognostic test that helps surgeons and endocrinologists to make important decisions on the clinical management of papillary thyroid cancer. Thyroid GuidePx® is performed on next generation sequencing (RNASeq). The test provides a molecular sub-classification of papillary thyroid cancer that is based on the expression of 82 genes. Thyroid GuidePx® simplifies prognostication, and identifies a low risk group with <5% recurrence rate.
    Cancer:
    Thyroid Gland Papillary Carcinoma
    Method:
    Next generation sequencing (NGS)